InvestorsHub Logo
Followers 27
Posts 2058
Boards Moderated 0
Alias Born 03/03/2005

Re: dakota post# 3725

Saturday, 03/21/2015 11:56:25 AM

Saturday, March 21, 2015 11:56:25 AM

Post# of 34618
I like the way the stock has performed sense Eastern Cap made their purchase. The following is a sample of their recent acquisitions, they seem to know and like undervalued Biotech.

http://biz.yahoo.com/t/89/8259.html

EASTERN CAPITAL LTD: Declared Holdings

Company/Relationship Reported Shares Ownership
Cyclacel Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:CYCC

(historical quotes, profile, other insiders) 9-Mar-15 5,607,143 Direct
Cytokinetics, Incorporated

Beneficial Owner (10% or more)
NasdaqCM:CYTK
(historical quotes, profile, other insiders) 25-Feb-14 2,883,845 Direct
iBio, Inc.
Beneficial Owner (10% or more)
NYSE MKT:IBIO

(historical quotes, profile, other insiders) 26-Apr-13 14,460,000 Direct

TAPIMMUNE INC
Beneficial Owner (10% or more)
Other OTC:TPIV
(historical quotes, other insiders) 9-Mar-15 5,000,000 Direct

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
9-Mar-15 5,607,143 CYCC Statement of Ownership
9-Mar-15 5,000,000 TPIV Statement of Ownership
25-Feb-14 500,000 CYTK Purchase at $8 per share.
(Cost of $4,000,000)
26-Apr-13 4,460,000 IBIO Purchase
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News